Medical News

RSS

Touch important for side-effects of medicines for premature babies with respiratory problems

Discovering that touch is important for the side-effects of a medicine for premature babies with respiratory problems. This is what Sanne Claessens finds so fascinating about fundamental research in medical pharmacology. PhD defence 27 June.

28 Jun 2012

BFC develops new Fertility App

Well in short the answer is yes if you are trying to conceive! And in this day and age where the smart phone is consulted over every aspect of day to day life, why shouldn't you rely on app to manage your love life as well! The Fertility App has been developed by Barbados Fertility Centre (BFC), a JCI accredited centre of excellence for IVF treatment located in the Caribbean and is the first app of its kind produced by a health care provider.

28 Jun 2012

Menopausal women may experience fewer hot flashes following physical activity

Menopausal women who exercise may experience fewer hot flashes in the 24 hours following physical activity, according to health researchers.

28 Jun 2012

California selects Accenture to implement CalHEERS

Accenture has been selected by the State of California, following a competitive bid process, to implement a statewide health insurance exchange, the California Healthcare Enrollment, Eligibility and Retention System (CalHEERS).

28 Jun 2012

Pediatric Hodgkin lymphoma can be treated without radiation and intensive chemotherapy

A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for second cancers, infertility, heart and other problems later.

28 Jun 2012

Up to 1 out of every 5 pregnant and new mothers will experience PPD and anxiety

Up to 1 out of every 5 pregnant and new mothers will experience prenatal or postpartum depression (PPD) and anxiety. Most women are undiagnosed and inadequately treated, if treated at all.

28 Jun 2012

HHS honors UNTHSC, Brookdale Senior Living with $7.3M Health Care Innovation award

The UNT Health Science Center and Brookdale Senior Living, the largest senior living community operator in the country, recently were awarded a $7.3 million Health Care Innovation award from the U.S. Department of Health and Human Services for a program designed to reduce hospital re-admissions of residents in assisted-living situations.

28 Jun 2012

Phototron launches new SG Sensors-brand sensors and controllers, growers

Phototron Holdings, Inc., a leading technology supplier to the hydroponic growing industry, today announced that its wholly owned SG Sensors division launched beta testing for its state-of-the-art wireless sensors and controllers, designed for growers of all sizes in the medicinal marijuana industry.

28 Jun 2012

Data from Infinity’s IPI-145 pre-clinical study on inflammatory diseases

Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.

28 Jun 2012

ACCP, OneBreath and COPD Alliance to unite on World Spirometry Day

The American College of Chest Physicians (ACCP), OneBreath, the COPD Alliance, and thousands of organizations worldwide will unite on World Spirometry Day, June 27, to promote lung health and elevate the status of often overlooked lung conditions, reinforcing the value of spirometry in the diagnosis of these conditions.

28 Jun 2012

BPI clinical study to evaluate computerized, brain-plasticity-based program for schizophrenia

Researchers at San Francisco-based Brain Plasticity, Inc. (BPI) have begun a multi-center study to evaluate the effects of a computerized, brain-plasticity-based program designed to address the cognitive issues associated with schizophrenia.

28 Jun 2012

Covidien introduces campaign to help educate women about risk of VTE during pregnancy

Covidien, a leading global provider of healthcare products, today announced the launch of its "1 in 1,000" campaign to help educate women about the risk of pregnancy-related blood clots, one of the leading causes of maternal mortality in the developed world.

28 Jun 2012

CHLA pediatric oncologist receives Hyundai Hope on Wheels grant

Weili Sun, MD, PhD, a pediatric oncologist at Children's Hospital Los Angeles, was awarded $75,000 by the Hyundai Hope on Wheels program. She will use this money to further her research into the role of epigenetics in cancer.

28 Jun 2012

OCC members praise FDA approval of new obesity drug – Belviq

Today, members of the Obesity Care Continuum (OCC) applauded the Food and Drug Administration's (FDA) approval of a new obesity drug – Belviq (lorcaserin HCl). Belviq is the first obesity drug to be approved in the past 13 years.

28 Jun 2012

Five medicine safety tips for families traveling with young children

With summer here and vacation season underway, the Centers for Disease Control and Prevention (CDC) and Consumer Healthcare Products Association (CHPA) Educational Foundation, in partnership with the PROTECT Initiative, today released five medicine safety tips for families traveling with young children.

28 Jun 2012

NUHHCE, AFSCME reach tentative contract agreement with Temple

Representatives of District 1199C of the National Union of Hospital and Health Care Employees (NUHHCE), AFSCME today reached a tentative contract agreement with representatives of Temple University Health Systems.

28 Jun 2012

Powerful new technique can manipulate the building-block molecules of organic chemistry

Scientists at The Scripps Research Institute have developed a powerful new technique for manipulating the building-block molecules of organic chemistry. The technique enables chemists to add new functional molecules to previously hard-to-reach positions on existing compounds-making it easier for them to generate new drugs and other organic chemicals.

28 Jun 2012

Study focuses on intergenerational dilemma

When we turn on the A/C in the summer, our first thought is probably one of relief. If it's 100 degrees in the shade, we're probably not thinking about how our decision might influence the environmental legacy we leave for future generations. It's not that we don't care, it's just that we typically don't think about our behavior in terms of long-term, inter-generational tradeoffs. But new research suggests that reminders of our own mortality may encourage us to keep future generations in mind as we make decisions.

28 Jun 2012

New compound could treat certain types of genetic disorders in muscles

Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.

28 Jun 2012

Gilead submits elvitegravir NDA with FDA for treatment of HIV-1 infection

Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

28 Jun 2012